Alteration of nuclear glyceraldehyde-3-phosphate dehydrogenase structure in Huntington's disease fibroblasts

Molecular Brain Research

Volumn 100, Issue 1-2, 2002, Pages 95-101

  Mazzola, Jennifer L ^a   Sirover, Michael A ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

GAPDH; Glyceraldehyde 3 phosphate dehydrogenase; Huntingtin; Huntington's disease; Subcellular fraction

Indexed keywords

GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HUNTINGTIN;

ARTICLE; CELL FRACTIONATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME STRUCTURE; FIBROBLAST; HUMAN; HUMAN CELL; HUNTINGTON CHOREA; MOLECULAR WEIGHT; PHENOTYPE; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

AGED; CELL NUCLEUS; CELLS, CULTURED; FIBROBLASTS; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; GLYCOLYSIS; HUMANS; HUNTINGTON DISEASE; INCLUSION BODIES; MACROMOLECULAR SUBSTANCES; MIDDLE AGED; MOLECULAR STRUCTURE; MOLECULAR WEIGHT; MUTATION; NERVE TISSUE PROTEINS; NORMAL DISTRIBUTION; NUCLEAR PROTEINS; PHENOTYPE; SUBCELLULAR FRACTIONS;

EID: 0037197778     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(02)00160-2     Document Type: Article

References (39)

1. p4A binding protein
2. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
3. Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH
4. Reduced apoptosis after nerve growth factor and serum withdrawal: Conversion of tetrameric glyceraldehyde-3-phosphate dehydrogenase to a dimer
5. Transglutaminase-catalyzed inactivation of glyceraldehyde-3-phosphate dehydrogenase and α-ketoglutarate dehydrogenase complex by polyglutamine domains of pathological length
6. Tissue transglutaminase-catalyzed formation of high-molecular weight aggregates in vitro is favored with long polyglutamine domains: A possible mechanism contributing to CAG-triplet diseases
7. Serial changes of cerebral glucose metabolism and caudate size in persons at risk for Huntington's disease
8. Nuclear and neuropil aggregates in Huntington's disease: Relationship to neuropathology
9. The influence of huntingtin protein size on nuclear localization and cellular toxicity
10. Nuclear localization of overexpressed glyceraldehyde-3-phosphate dehydrogenase in cultured cerebellar neurons undergoing apoptosis
11. Transglutaminase aggregates huntingtin into nonamyloidogenic polymers, and its enzymatic activity increases in Huntington's disease brain nuclei
12. Brain glyceraldehyde-3-phosphate dehydrogenase activity in human trinucleotide repeat disorders
13. Spinocerebellar ataxia type-1 and spinobulbar muscular atrophy gene products interact with glyceraldehyde-3-phosphate dehydrogenase
14. Huntingtin aggregates may not predict neuronal death in Huntington's disease
15. Cerebral metabolism and atrophy in Huntington's disease determined by 18FDG and computed tomographic scan
16. A porcine brain protein (35k protein) which bundles microtubules and its identification as glyceraldehyde-3-phosphate dehydrogenase
17. Recent insights into the molecular pathogenesis of Huntington's disease
18. Physical association of base excision repair enzymes with parental and replicating DNA in BHK-21 cells
19. Tissue transglutaminase is increased in Huntington's disease brain
20. The early cellular pathology of Huntington's disease
21. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice
22. Reduction of glyceraldehydes-3-phosphate dehydrogenase activity in Alzheimer's disease and in Huntington's disease fibroblasts
23. A human nuclear uracil DNA glycosylase is the 37-kDa subunit of glyceraldehyde-3-phosphate dehydrogenase
24. Binding constants and stoichiometries of glyceraldehyde-3-phosphate dehydrogenase-tubulin complexes
25. Recent advances on the pathogenesis of Huntington's disease
26. Recent advances in understanding the pathogenesis of Huntington's disease
27. Heterogeneity of glyceraldehyde-3-phosphate dehydrogenase from human brain
28. Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions
29. Subcellular distribution of glyceraldehyde-3-phosphate dehydrogenase in cerebellar granule cells undergoing cytosine arabinoside-induced apoptosis
30. Nuclear translocation of glyceraldehyde-3-phosphate dehydrogenase isoforms during neuronal apoptosis
31. Glyceraldehyde-3-phosphate dehydrogenase: Nuclear translocation participates in neuronal and nonneuronal cell death
32. Nuclear translocation of GAPDH-GFP fusion protein during apoptosis
33. Huntington's disease intranuclear inclusions contain truncated, ubiquinated huntingtin protein
34. Sequence-specificity binding of transfer RNA by glyceraldehyde-3-phosphate dehydrogenase
35. New insights into an old protein: The functional diversity of mammalian glyceraldehyde-3-phosphate dehydrogenase
36. Biochemical abnormalities and excitotoxicity in Huntington's disease brain
37. Huntington's disease gene product, huntingtin, associates with microtubules in vitro
38. Positive correlation between the extent of cell proliferation and the regulation of base excision repair
39. Identification of glyceraldehyde-3-phosphate dehydrogenase as a cellular protein that binds to the hepatitis B virus posttranslational regulatory element